Global Pharyngoconjunctival Fever Market – Industry Trends and Forecast to 2031

Pharyngoconjunctival Fever Market Analysis and Size

The National Institute of Infectious Diseases in Japan has reported a decade-high number of cases of pharyngoconjunctival fever, also known as swimming pool fever. This summer illness, common among children and often transmitted in swimming pools, has prompted alerts in Osaka and Fukuoka prefectures due to increased cases.  The disease is mainly transmitted through droplets and contact, including shared towels. Monitoring of pediatric hospitals revealed an average of 1.45 patients per institution, exceeding previous decade highs. Fukuoka and Osaka prefectures have seen averages above the alert threshold of 3, with 4.65 and 4.09 patients respectively. The outbreak is particularly pronounced in the Kansai region, with figures of 2.95, 2.88, and 2.19 in Kyoto, Nara, and Hyogo prefectures respectively. Authorities are emphasizing hygiene practices and caution, as the virus can persist in urine and feces for up to a month after symptoms resolve.

The global pharyngoconjunctival fever market size was valued at USD 9.52 billion in 2023 and is projected to reach USD 15.99 billion by 2031, with a CAGR of 6.70% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Market Definition

Pharyngoconjunctival fever is a viral infection characterized by inflammation of the pharynx (the back of the throat) and conjunctiva (the mucous membrane that covers the front of the eye and lines the inside of the eyelids). It is typically caused by adenoviruses and is characterized by symptoms such as sore throat, redness and irritation of the eyes, fever, and sometimes swollen lymph nodes.    

Pharyngoconjunctival Fever Market Dynamics

Drivers

• Increasing Prevalence of Adenovirus Infections          

 Adenoviruses are a common cause of respiratory and gastrointestinal infections, and they can also lead to PCF. The increasing incidence of adenovirus infections is paralleled by a rise in PCF cases, fueling the demand for treatments and management options. This growing prevalence is particularly notable in settings where close contact among individuals is common, such as schools, military barracks, and daycare centers. The increasing recognition of adenoviruses as a significant pathogen, along with the development of more sensitive diagnostic tests, is also contributing to the rise in reported cases of PCF. This is expected to continue to drive market growth for PCF treatments.

• Rising Awareness and Diagnosis

There is a growing awareness among healthcare professionals about PCF, leading to improved diagnosis and treatment. Healthcare providers are becoming more adept at recognizing the symptoms of PCF and distinguishing it from other similar conditions. This trend towards accurate diagnosis and appropriate treatment is expected to drive market growth as more cases are identified and managed effectively. The increasing awareness about PCF is also leading to better patient outcomes and reduced complications, further driving the demand for PCF treatments.       

Opportunities

• Increasing Healthcare Expenditure      

As more resources are allocated to healthcare, there is a greater focus on managing and treating common viral infections such as PCF. This includes investment in healthcare infrastructure, diagnostic tools, and treatments. The growing healthcare expenditure is expected to drive market growth for PCF treatments as more people have access to healthcare services and are able to seek treatment for their symptoms. The increasing healthcare expenditure, particularly in developing regions, presents a significant market opportunity for PCF treatments.          

• Growing Demand for Symptomatic Relief     

PCF is characterized by symptoms such as sore throat and fever, which can be uncomfortable and debilitating. As a result, there is a strong demand for over-the-counter medications and remedies that can provide relief from these symptoms. This includes pain relievers, fever reducers, and throat lozenges, among other products. The market for these products is expected to grow as the incidence of PCF increases, and more people seek relief from their symptoms. The demand for symptomatic relief for Pharyngoconjunctival fever (PCF) presents a significant market opportunity.

Restraints/Challenges

• Seasonal Variations in Incidence        

Adenovirus infections tend to be more common in certain seasons, such as late winter and early spring, leading to fluctuations in demand for PCF treatments. The seasonal fluctuations pose challenges for healthcare providers and pharmaceutical companies in forecasting and preparing for the demand for PCF treatments. In addition, the seasonal nature of adenovirus infections highlights the importance of timely and targeted interventions to manage outbreaks and reduce the burden of PCF during peak seasons. Seasonal variations in the incidence of adenovirus infections, and consequently PCF, can pose challenges for the market.       

• Lack of Specific Treatment         

PCF is caused by adenoviruses, which are not susceptible to antibiotics, so treatment focuses on managing symptoms. This limitation in treatment options can hinder market growth as patients and healthcare providers seek more targeted and effective therapies. The absence of a specific treatment also underscores the importance of preventive measures, such as hygiene practices and vaccination against adenoviruses, which could reduce the incidence of PCF and its impact on affected individuals. The lack of specific treatments for Pharyngoconjunctival fever (PCF) is a major restraint for the market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Pharyngoconjunctival Fever Market Scope

The market is segmented on the basis of causes, treatment, distribution channel, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Causes

• Fever
• Pharyngitis
• Acute Follicular Conjunctivitis
• Regional Lymphoid Hyperplasia with Tender
• Enlarged Preauricular Adenopathy

Treatment

• Cold Compresses
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

SKU-63028